Related Articles
High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group
Short‑course bortezomib‑based retreatment for patients with multiple myeloma who had received bortezomib‑thalidomide‑dexamethasone (VTD) as an initial therapy: A single‑center case series
Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity
Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report
Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non‑Hodgkin's lymphoma: A prospective study of 46 cases